The United Kingdom

Following the 1990 NHS reforms, health technology assessment (HTA) in the United Kingdom has become the largest and most developed of the NHS Research and Development (R&D) Strategy. A strategy that was created to promote a knowledge-based health service with a strong research infrastructure and the capacity to critically review its own needs. HTA in the UK has a formal system for setting assessment priorities involving widespread consultation within the NHS, and a National Co-ordinating Centre for Health Technology Assessment. A hallmark of the UK HTA program is the strong public participation.


NICE recommends thyroid cancer drug trio for NHS use

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use of the NHS: Ipsen’s Cometriq (cabozantinib), Bayer’s Nexavar (sorafenib), and Eisai’s Lenvima (lenvatinib). The former two were previously only available via the Cancer Drugs Fund (CDF), and the latter sees […]


Lilly dumps Hanmi’s rheumatoid arthritis med

Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, for the treatment of various autoimmune and other diseases in 2015. The deal was worth a potential $690 million in total but that hasn’t stopped Lilly showing every sign of […]


Ovarian cancer risk may be inherited from the father, research indicates

Image Credit: Zappys Technology Solutions, https://www.flickr.com/photos/102642344@N02/10136583214 Researchers at the Roswell Park Comprehensive Cancer Centre in New York have published findings indicating that ovarian cancer risk may be inherited through a gene on the X chromosome of the patient’s father, independently of other genes which have already been linked to the […]


Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children

  Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children Wyatt K, Lloyd J, Creanor S, Green C, Dean S G, Hillsdon M, Abraham C, Tomlinson R, Pearson V, […]